Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a peripheral vasodilator and smooth muscle relaxant. Its exact mechanism of action is not fully understood but is thought to involve direct relaxation of vascular smooth muscle and potentially beta-adrenergic stimulation.
## Primary Indications
* Treatment of peripheral vascular disease, such as intermittent claudication.
* Historically used to improve cerebral blood flow, but efficacy is not well-established.
## Adult Dosing
* **Intermittent Claudication/Peripheral Vascular Disease:** 10-20 mg orally three to four times daily.
* Dosing may be adjusted based on patient response and tolerability.
## Pediatric Dosing
There is no established pediatric dosing for isoxsuprine hydrochloride. Its use in children is generally not recommended due to lack of safety and efficacy data.
## Dose Adjustments
No specific dose adjustments are recommended for hepatic or renal impairment. However, caution should be exercised, and lower doses may be considered in patients with significant organ dysfunction.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use with caution in patients with glaucoma, severe hypotension, or cardiac arrhythmias.
## Adverse Effects
Common adverse effects include:
* Gastrointestinal upset (nausea, vomiting, abdominal distress)
* Dizziness, lightheadedness
* Weakness
* Flushing
* Hypotension
* Tachycardia
Less common but serious effects include:
* Exacerbation of hypotension and tachycardia in susceptible individuals.
* Paradoxical pressor response.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* **Sympathomimetic Agents:** May increase the risk of cardiovascular side effects like tachycardia and arrhythmias.
## Monitoring
* Blood pressure and heart rate.
* Signs and symptoms of peripheral vascular disease.
* Adverse effects, particularly cardiovascular ones.
## Clinical Pearls
* Isoxsuprine's efficacy in peripheral vascular disease is often modest and should be considered as adjunctive therapy to lifestyle modifications (e.g., smoking cessation, exercise).
* Onset of action is typically within 30 minutes to 1 hour.
* Monitor patients closely for hypotension and tachycardia, especially at higher doses or in combination with other cardiovascular agents.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making therapeutic decisions. Drug information can change rapidly, and individual patient factors must be considered.
